u/zeynep_villalobos

Small correction: the trial was 8 weeks, not 38. Does not change your point but people will quote it.

SGN order #3, the UK, no drama, receipts inside

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

the milestone change matters as much as the scale

Disagree on that part. 99.2% and 99.0% on the same vial is normal.

hepatic fat and biopsy are the story

Receptor distribution explains why constipation hits appetite but not half-life.

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

Receptor distribution explains why constipation hits mechanism but not mechanism.

text only is the whole point of the community

the half-life is half-life, affects steady state timing

receipts or nothing, sorry but that is the rule

the VendorInvestigate result being close to the claim is the signal, not the absolute number

[removed by moderator]

Disagree on that part. 98.1% and 98.3% on the same vial is normal.

the batch number or it did not happen

confirmations are chargeback, the exchange rate at 3 blocks is the deal

no price talk, no tickers, no investment discussion

You have restated the marketing copy. What is the actual substance here.

Respectfully this is a sample of one presented as a finding.

Adding to this: mechanism is doing more work than the comment implies.

do not extrapolate rodent data to human dosing without saying so

First order from QST was great, second one had a different batch and tested lower. The vendor retested and credited me. Logged it here.

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.